1-4 of 4
Kerol Bartolovic
Close
Sort by
Journal Articles

Non-Cycling Cells From Acute Myeloid Leukemia Patients Harbor the FLT3-ITD Mutation and Are Insensitive to TKI258, a Potent FLT3-Directed Inhibitor, in Vitro .

Caroline L Alvares, Tino Schenk, Sanna Hulkki, Toon Min, Gowri Vijayaraghavan, Yeung Jenny, David Gonzalez, Eric So, Mel Greaves, Ian Titley, Kerol Bartolovic, Gareth Morgan
Journal: Blood
Blood (2009) 114 (22): 479.
https://doi.org/10.1182/blood.V114.22.479.479
Published: 2009
Journal Articles

The Tyrosine Kinase Inhibitor TK258 Differentially Targets Proliferating Human Hematopoietic Progenitor Cells but Does Not Eliminate the Quiescent Fraction.

Caroline Alvares, Ian Titley, Mel Greaves, Michael Potter, Lyndal Kearney, Gareth Morgan, Kerol Bartolovic
Journal: Blood
Blood (2007) 110 (11): 3356.
https://doi.org/10.1182/blood.V110.11.3356.3356
Published: 2007
Journal Articles

Inhibitory effect of imatinib on normal progenitor cells in vitro

Kerol Bartolovic, Stefan Balabanov, Ulrike Hartmann, Martina Komor, Andreas M. Boehmler, Hans-Jörg Bühring, Robert Möhle, Dieter Hoelzer, Lothar Kanz, Wolf-Karsten Hofmann, Tim H. Brümmendorf
Journal: Blood
Blood (2004) 103 (2): 523–529.
https://doi.org/10.1182/blood-2003-05-1535
Published: 2004
Journal Articles

Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia

Tim H. Brümmendorf, Inci Ersöz, Ulrike Hartmann, Kerol Bartolovic, Stefan Balabanov, Alexandra Wahl, Peter Paschka, Sebastian Kreil, Tanja Lahaye, Ute Berger, Harald Gschaidmeier, Carsten Bokemeyer, Rüdiger Hehlmann, Klaus Dietz, Peter M. Lansdorp, Lothar Kanz, Andreas Hochhaus
Journal: Blood
Blood (2003) 101 (1): 375.
https://doi.org/10.1182/blood-2002-08-2557
Published: 2003